Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience

References

• Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer. Lancet. 2021;397(10272):428–444. doi:10.1016/s0140-6736(21)00153-7
   PubMed Web of Science ®Google Scholar
• Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588. doi:10.1038/s41575-020-0310-z
   PubMed Web of Science ®Google Scholar
• Alvaro D, Hassan C, Cardinale V, et al. Italian clinical practice guidelines on cholangiocarcinoma – part I: classification, diagnosis and staging. Dig Liver Dis. 2020;52(11):1282–1293. doi:10.1016/j.dld.2020.06.045
   PubMedGoogle Scholar
• Li J, Moustafa M, Linecker M, et al. ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study. Ann Surg Oncol. 2020;27(5):1372–1384. doi:10.1245/s10434-019-08192-z
   PubMed Web of Science ®Google Scholar
• Pavicevic S, Reichelt S, Uluk D, et al. Prognostic and predictive molecular markers in cholangiocarcinoma. Cancers. 2022;14(4):1026. doi:10.3390/cancers14041026
   PubMed Web of Science ®Google Scholar
• Ronnekleiv-Kelly SM, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(1):35–43. doi:10.21037/hbsn.2016.10.02
   PubMed Web of Science ®Google Scholar
• Saito H, Noji T, Okamura K, et al. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016;159(3):842–851. doi:10.1016/j.surg.2015.10.027
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang Y-G, Li H-C, et al. Transiently elevated TC and sdLDL-C levels and falsely low LDL-C levels in patients with extrahepatic cholangiocarcinoma. Onco Targets Ther. 2021;14:1061–1071. doi:10.2147/ott.S285856
   PubMed Web of Science ®Google Scholar
• Z-q L, Ma C, Cao W-Z, et al. Prognostic significance of NLR, PLR, LMR and tumor infiltrating T lymphocytes in patients undergoing surgical resection for hilar cholangiocarcinoma. Front Oncol. 2022;12. doi:10.3389/fonc.2022.908907
   Web of Science ®Google Scholar
• Wang A, He Z, Cong P, et al. Controlling Nutritional Status (CONUT) score as a new indicator of prognosis in patients with hilar cholangiocarcinoma is superior to NLR and PNI: a single-center retrospective study. Front Oncol. 2021;10. doi:10.3389/fonc.2020.593452
   Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum. 2017;60(12):1273–1284. doi:10.1097/dcr.0000000000000961
   PubMed Web of Science ®Google Scholar
• Feng J-F, Zhao J-M, Chen S, et al. Naples prognostic score: a novel prognostic score in predicting cancer-specific survival in patients with resected esophageal squamous cell carcinoma. Front Oncol. 2021;11. doi:10.3389/fonc.2021.652537
   Google Scholar
• Wang H, Fang T, Yin X, et al. Prognostic importance of the preoperative New-Naples prognostic score for patients with gastric cancer. Cancer Med. 2022;12(2):1358–1375. doi:10.1002/cam4.5017
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Yamada S, Sonohara F, et al. Clinical implications of Naples prognostic score in patients with resected pancreatic cancer. Ann Surg Oncol. 2019;27(3):887–895. doi:10.1245/s10434-019-08047-7
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nat Immunol. 2017;18(8):843–850. doi:10.1038/ni.3754
   PubMed Web of Science ®Google Scholar
• Kiely M, Lord B, Ambs S. Immune response and inflammation in cancer health disparities. Trends Cancer. 2022;8(4):316–327. doi:10.1016/j.trecan.2021.11.010
   PubMed Web of Science ®Google Scholar
• Buettner S, Spolverato G, Kimbrough CW, et al. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery. 2018;164(3):411–418. doi:10.1016/j.surg.2018.05.002
   PubMed Web of Science ®Google Scholar
• Lv M, Wang K, Zhang Z, et al. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection. Cancer Med. 2023;12(8):9482–9495. doi:10.1002/cam4.5712
   PubMed Web of Science ®Google Scholar
• Huang H, Zhang L, Chen D-B, et al. Validation of prognosis value of cumulative prognostic scores based on serum high-density lipoprotein cholesterol and albumin levels in patients with colorectal cancer. J Cancer. 2019;10(1):35–42. doi:10.7150/jca.26637
   PubMed Web of Science ®Google Scholar
• Feng Z, Pang K, Tian M, et al. Sarcobesity, but not visceral fat, is an independent risk factor for complications after radical resection of colorectal cancer. Front Nutr. 2023;10. doi:10.3389/fnut.2023.1126127
   Web of Science ®Google Scholar
• Carnevale S, Di Ceglie I, Grieco G, et al. Neutrophil diversity in inflammation and cancer. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1180810
   Web of Science ®Google Scholar
• Caprara G, Allavena P, Erreni M. Intestinal macrophages at the crossroad between diet, inflammation, and cancer. Int J Mol Sci. 2020;21(14):4825. doi:10.3390/ijms21144825
   PubMed Web of Science ®Google Scholar
• Kuroda D, Sawayama H, Kurashige J, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2017;21(2):204–212. doi:10.1007/s10120-017-0744-3
   PubMed Web of Science ®Google Scholar
• Chen L, Bai P, Kong X, et al. Prognostic Nutritional Index (PNI) in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator. Front Cell Develop Biol. 2021;9. doi:10.3389/fcell.2021.656741
   Web of Science ®Google Scholar
• Lleo A, Colapietro F, Maisonneuve P, et al. Risk stratification of cholangiocarcinoma patients presenting with jaundice: a retrospective analysis from a tertiary referral center. Cancers. 2021;13(9):2070. doi:10.3390/cancers13092070
   PubMed Web of Science ®Google Scholar
• Zhang G, Chen B-W, Yang X-B, et al. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: a retrospective multicenter cohort study. World J Gastroenterol. 2022;28(41):5968–5981. doi:10.3748/wjg.v28.i41.5968
   PubMed Web of Science ®Google Scholar
• Izquierdo-Sanchez L, Lamarca A, La Casta A, et al. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry. J Hepatol. 2022;76(5):1109–1121. doi:10.1016/j.jhep.2021.12.010
   PubMed Web of Science ®Google Scholar
• Clements O, Eliahoo J, Kim JU, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95–103. doi:10.1016/j.jhep.2019.09.007
   PubMed Web of Science ®Google Scholar
• Montal R, Sia D, Montironi C, et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J Hepatol. 2020;73(2):315–327. doi:10.1016/j.jhep.2020.03.008
   PubMed Web of Science ®Google Scholar